182 related articles for article (PubMed ID: 16098147)
21. Nuclear translocation of the SRF co-activator MAL in cortical neurons: role of RhoA signalling.
Tabuchi A; Estevez M; Henderson JA; Marx R; Shiota J; Nakano H; Baraban JM
J Neurochem; 2005 Jul; 94(1):169-80. PubMed ID: 15953360
[TBL] [Abstract][Full Text] [Related]
22. Repression of SOX6 transcriptional activity by SUMO modification.
Fernández-Lloris R; Osses N; Jaffray E; Shen LN; Vaughan OA; Girwood D; Bartrons R; Rosa JL; Hay RT; Ventura F
FEBS Lett; 2006 Feb; 580(5):1215-21. PubMed ID: 16442531
[TBL] [Abstract][Full Text] [Related]
23. Repression of the estrogen receptor-alpha transcriptional activity by the Rho/megakaryoblastic leukemia 1 signaling pathway.
Huet G; Mérot Y; Percevault F; Tiffoche C; Arnal JF; Boujrad N; Pakdel F; Métivier R; Flouriot G
J Biol Chem; 2009 Dec; 284(49):33729-39. PubMed ID: 19826002
[TBL] [Abstract][Full Text] [Related]
24. Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation.
Selvaraj A; Prywes R
J Biol Chem; 2003 Oct; 278(43):41977-87. PubMed ID: 14565952
[TBL] [Abstract][Full Text] [Related]
25. Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization.
Muehlich S; Wang R; Lee SM; Lewis TC; Dai C; Prywes R
Mol Cell Biol; 2008 Oct; 28(20):6302-13. PubMed ID: 18694962
[TBL] [Abstract][Full Text] [Related]
26. The transcriptional regulator megakaryoblastic leukemia-1 mediates serum response factor-independent activation of tenascin-C transcription by mechanical stress.
Asparuhova MB; Ferralli J; Chiquet M; Chiquet-Ehrismann R
FASEB J; 2011 Oct; 25(10):3477-88. PubMed ID: 21705668
[TBL] [Abstract][Full Text] [Related]
27. Filamin A interacts with the coactivator MKL1 to promote the activity of the transcription factor SRF and cell migration.
Kircher P; Hermanns C; Nossek M; Drexler MK; Grosse R; Fischer M; Sarikas A; Penkava J; Lewis T; Prywes R; Gudermann T; Muehlich S
Sci Signal; 2015 Nov; 8(402):ra112. PubMed ID: 26554816
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
29. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
Schmidt D; Müller S
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732
[TBL] [Abstract][Full Text] [Related]
30. Sumoylated SnoN represses transcription in a promoter-specific manner.
Hsu YH; Sarker KP; Pot I; Chan A; Netherton SJ; Bonni S
J Biol Chem; 2006 Nov; 281(44):33008-18. PubMed ID: 16966324
[TBL] [Abstract][Full Text] [Related]
31. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.
Tirard M; Almeida OF; Hutzler P; Melchior F; Michaelidis TM
Mol Cell Endocrinol; 2007 Mar; 268(1-2):20-9. PubMed ID: 17314004
[TBL] [Abstract][Full Text] [Related]
32. Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification.
Izumiya Y; Ellison TJ; Yeh ET; Jung JU; Luciw PA; Kung HJ
J Virol; 2005 Aug; 79(15):9912-25. PubMed ID: 16014952
[TBL] [Abstract][Full Text] [Related]
33. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.
Subramanian L; Benson MD; Iñiguez-Lluhí JA
J Biol Chem; 2003 Mar; 278(11):9134-41. PubMed ID: 12511558
[TBL] [Abstract][Full Text] [Related]
34. Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression.
Cen B; Selvaraj A; Prywes R
J Cell Biochem; 2004 Sep; 93(1):74-82. PubMed ID: 15352164
[TBL] [Abstract][Full Text] [Related]
35. Sumoylation of a meiosis-specific RecA homolog, Lim15/Dmc1, via interaction with the small ubiquitin-related modifier (SUMO)-conjugating enzyme Ubc9.
Koshiyama A; Hamada FN; Namekawa SH; Iwabata K; Sugawara H; Sakamoto A; Ishizaki T; Sakaguchi K
FEBS J; 2006 Sep; 273(17):4003-12. PubMed ID: 16879611
[TBL] [Abstract][Full Text] [Related]
36. The UBC9 E2 SUMO conjugating enzyme binds the PR-Set7 histone methyltransferase to facilitate target gene repression.
Spektor TM; Congdon LM; Veerappan CS; Rice JC
PLoS One; 2011; 6(7):e22785. PubMed ID: 21829513
[TBL] [Abstract][Full Text] [Related]
37. SUMOylation modulates transcriptional repression by TRPS1.
Kaiser FJ; Lüdecke HJ; Weger S
Biol Chem; 2007 Apr; 388(4):381-90. PubMed ID: 17391059
[TBL] [Abstract][Full Text] [Related]
38. Modulation of PLAGL2 transactivation activity by Ubc9 co-activation not SUMOylation.
Guo Y; Yang MC; Weissler JC; Yang YS
Biochem Biophys Res Commun; 2008 Sep; 374(3):570-5. PubMed ID: 18655774
[TBL] [Abstract][Full Text] [Related]
39. RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.
Yan J; Yang XP; Kim YS; Joo JH; Jetten AM
Biochem Biophys Res Commun; 2007 Oct; 362(1):132-138. PubMed ID: 17698038
[TBL] [Abstract][Full Text] [Related]
40. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
Yunus AA; Lima CD
Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
